Crescita Therapeutics Inc (CTX : TSX)
Common Stock
Follow CTX
CTX
Crescita Therapeutics Inc
Performance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
+64.58%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$14.71M
52W High
$0.79
52W Low
$0.40
P/E Ratio
-
50 Day MA
$0.75
200 Day MA
$0.55
Beta
-0.14
Dividend Yield
-
Performance history
CTX returns since 2023
Crescita Therapeutics Inc has traded since Nov 2023 in our data, with 1 up year out of 2 full calendar years. Its deepest fall was −38.1% (Aug 2024 to Nov 2025).
1 year / yr
+49.1%
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*+16.7%
- 2024+18.4%
- 2025−17.2%
- 2026*+64.6%
* Partial year (first year of data, or year to date).
$10,000 invested in CTX
- 1 year ago$14,906
- 2023 (start of our data)$18,810
- Best year
- 2024: +18.4%
- Worst year
- 2025: −17.2%
- All-time high in our data
- $1 on Jun 2, 2026 · at the high
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Jun 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past CTX? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/4/2026 | $0.79 | $0.79 | $0.79 | $0.79 | $0.79 | 1,164 |
| 6/3/2026 | $0.79 | $0.79 | $0.79 | $0.79 | $0.79 | 92,771 |
| 6/2/2026 | $0.79 | $0.79 | $0.79 | $0.79 | $0.79 | 4,646 |
| 6/1/2026 | $0.75 | $0.75 | $0.75 | $0.75 | $0.75 | 0 |
| 5/29/2026 | $0.75 | $0.75 | $0.75 | $0.75 | $0.75 | 0 |
| 5/28/2026 | $0.75 | $0.75 | $0.75 | $0.75 | $0.75 | 989 |
| 5/27/2026 | $0.75 | $0.75 | $0.75 | $0.75 | $0.75 | 0 |
| 5/26/2026 | $0.75 | $0.75 | $0.75 | $0.75 | $0.75 | 1,299 |
| 5/25/2026 | $0.75 | $0.75 | $0.75 | $0.75 | $0.75 | 0 |
| 5/22/2026 | $0.75 | $0.75 | $0.75 | $0.75 | $0.75 | 3,560 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CTX's historical volatility
30-Day Vol
16.4%
Annualized
90-Day Vol
80.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.94
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.84 | C$0.79 – C$0.89 |
| 60 trading days | C$0.89 | C$0.82 – C$0.96 |
| 90 trading days | C$0.94 | C$0.86 – C$1.04 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Crescita Therapeutics Inc
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary drug delivery platforms, which include Multiplexed Molecular Penetration Enhancers and DuraPee that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures. Its non-prescription portfolio offers dermocosmetic products, such as face creams, cleansers, exfoliants, masks, serums, and suncare to treat mild acne, aging, dehydration, pigmentation, sensitivity, and rosacea under the Laboratoire Dr Renaud and Aquafolia brands; and medical aesthetics under the Pro-Derm and Alyria brands for non-invasive and minimally invasive procedures or skincare treatments. The company also distributes Bacti Control, a solution for hand hygiene; NCTF Boost 135 HA, a skin revitalization solution; Obagi Medical products; ART FILLER, a hyaluronic acid-based dermal filler; and MicronJet, an intradermal injection device. The company has commercialization license agreement with Cantabria Labs Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.
Financials
- Revenue (TTM)
- $23.22M
- EBITDA
- $-65,000
- Profit Margin
- -1.38%
- ROE (TTM)
- -2.19%
- EPS (Diluted)
- -0.01
- Book Value
- 0.78
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About CTX
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GRC | Gold Springs Resource Corp | $0.06 | +37.50% |
| MDNA | Medicenna Therapeutics Corp | $0.22 | +22.22% |
| DRX | ADF Group Inc. | $20.78 | +20.88% |
| DND | Dye & Durham Ltd | $0.98 | +13.95% |
| T | Telus Corp | $15.50 | +13.72% |
| BU | Burcon NutraScience Corporation | $0.85 | +13.33% |
| DII-B | Dorel Industries Inc | $1.35 | +8.87% |
| PYR | PyroGenesis Canada Inc. | $0.19 | +8.57% |
Free with a Wealth Awesome account
Keep analysing CTX, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.